Gonadorelin

Lutrepulse PWS 0.8MG/Vial

0.8 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 31 Dec 1994

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Lutrepulse KitUnited States · 0.8MG/VIAL, 3.2MG/VIAL · injectable · FerringSame brand
ParlibBrazil · Laboratorio Enila Ind. e Com. de Prod. Quim. e Farmac. S/ASame substance
KryptocurItaly · Spray nasale, soluzione · Cheplapharm Arzneimittel GMBHSame substance
Lutrelef 0,1 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Ferring B.V.Same substance
Lutrelef 3,2 mg, poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Ferring B.V.Same substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Gonadorelin

Lutrepulse PWS 0.8MG/Vial

0.8 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 31 Dec 1994

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

FactrelUnited States · 0.1MG BASE/VIAL, 0.2MG BASE/VIAL, 0.5MG BASE/VIAL · injectable · Hikma

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Gonadorelin
Strength: 0.8 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous, Subcutaneous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1994
Registration: DIN 02046210
Marketing authorisation holder: Ferring INC
ATC code: H01CA01
Group: Systemic hormonal preparations
Supply: PRESCRIPTION

Fertagyl 2Gonadorelin · 43 MCG / ML · SolutionCanadaMarketed

FertilineGonadorelin · 50 MCG / ML · SolutionCanadaMarketed

GonabreedGonadorelin · 100 MCG / ML · SolutionCanadaMarketed

GonavetGonadorelin · 54 MCG / ML · SolutionCanadaMarketed

OvarelinGonadorelin · 50 MCG / ML · SolutionCanadaMarketed

Factrel Inj 0.5MG/VialGonadorelin · .5 MG / VIAL · Powder For SolutionCanadaCancelled

Factrel PWS 100MCG/VialGonadorelin · 100 MCG / VIAL · Powder For SolutionCanadaCancelled

Factrel PWS 500MCG/VialGonadorelin · 500 MCG / VIAL · Powder For SolutionCanadaCancelled

Fertagyl Injection 100MCG/MLGonadorelin · 100 MCG / ML · SolutionCanadaCancelled